The Multifunctional role and therapeutic potential of HO-1 in the vascular endothelium

Antioxidants and Redox Signaling

Volumn 20, Issue 11, 2014, Pages 1789-1809

  Calay, Damien ^a   Mason, Justin C ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; BILIVERDIN; CARBON MONOXIDE; HEME OXYGENASE 1;

DRUG EFFICACY; DRUG SAFETY; ENDOTHELIUM CELL; ENZYME INDUCTION; GENE TARGETING; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE SPECIFICITY; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ANIMALS; ATHEROSCLEROSIS; BILIRUBIN; BILIVERDINE; CARBON MONOXIDE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME INDUCTION; HEME OXYGENASE-1; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 84896343373     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5659     Document Type: Review

References (200)

1. Abraham NG, Scapagnini G, and Kappas A. Human heme oxygenase: cell cycle-dependent expression and DNA mi-croarray identification of multiple gene responses after transduction of endothelial cells. J Cell Biochem 90: 1098-1111, 2003.
2. Adachi T, Ishikawa K, Hida W, Matsumoto H, Masuda T, Date F, Ogawa K, Takeda K, Furuyama K, Zhang Y, Kita-muro T, Ogawa H, Maruyama Y, and Shibahara S. Hy-poxemia and blunted hypoxic ventilatory responses in mice lacking heme oxygenase-2. Biochem Biophys Res Commun 320: 514-522, 2004.
3. Adin CA, Croker BP, and Agarwal A. Protective effects of exogenous bilirubin on ischemia-reperfusion injury in the isolated, perfused rat kidney. Am J Physiol Renal Physiol 288: F778-F784, 2005.
4. Alam J, Cai J, and Smith A. Isolation and characterization of the mouse heme oxygenase-1 gene. Distal 5¢ sequences are required for induction by heme or heavy metals. J Biol Chem 269: 1001-1009, 1994.
5. Alam J, Camhi S, and Choi AM. Identification of a second region upstream of the mouse heme oxygenase-1 gene that functions as a basal level and inducer-dependent transcription enhancer. J Biol Chem 270: 11977-11984, 1995.
6. Alam J and Cook JL. How many transcription factors does it take to turn on the heme oxygenase-1 gene? Am J Respir Cell Mol Biol 36: 166-174, 2007.
7. Ali F, Ali NS, Bauer A, Boyle JJ, Hamdulay SS, Haskard DO, Randi AM, and Mason JC. PPARd and PGC1a act cooperatively to induce haem oxygenase-1 and enhance vascular endothelial cell resistance to stress. Cardiovasc Res 85: 701-710, 2010.
8. Ali F, Hamdulay SS, Kinderlerer AR, Boyle JJ, Lidington EA, Yamaguchi T, Soares MP, Haskard DO, Randi AM, and Mason JC. Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1. J Thromb Hae-most 5: 2537-2546, 2007.
9. Ali F, Zakkar M, Karu K, Lidington EA, Hamdulay SS, Boyle JJ, Zloh M, Bauer A, Haskard DO, Evans PC, and Mason JC. Induction of the cytoprotective enzyme heme oxygenase-1 by statins is enhanced in vascular endothe-lium exposed to laminar shear stress. J Biol Chem 284: 18882-18892, 2009.
10. Alshehri A, Bourguignon MP, Clavreul N, Badier-Commander C, Gosgnach W, Simonet S, Vayssettes-Courchay C, Cordi A, Fabiani JN, Verbeuren TJ, and Feletou M. Mechanisms of the vasorelaxing effects of CORM-3, a water-soluble carbon monoxide-releasing molecule: interactions with eNOS. Naunyn Schmiedebergs Arch Pharmacol 386: 185-196, 2013.
11. Angermayr B, Mejias M, Gracia-Sancho J, Garcia-Pagan JC, Bosch J, and Fernandez M. Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats. J Hepatol 44: 1033-1039, 2006.
12. Araujo JA, Zhang M, and Yin F. Heme oxygenase-1, oxidation, inflammation, and atherosclerosis. Front Pharmacol 3: 119, 2012.
13. Bai CH, Chen JR, Chiu HC, Chou CC, Chau LY, and Pan WH. Shorter GT repeat polymorphism in the heme oxy-genase-1 gene promoter has protective effect on ische-mic stroke in dyslipidemia patients. J Biomed Sci 17: 12, 2010.
14. Balla G, Vercellotti GM, Muller-Eberhard U, Eaton J, and Jacob HS. Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab Invest 64: 648-655, 1991.
15. Baranano DE, Rao M, Ferris CD, and Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 99: 16093-16098, 2002.
16. Barone E, Di Domenico F, Sultana R, Coccia R, Mancuso C, Perluigi M, and Butterfield DA. Heme oxygenase-1 post-translational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment. Free Radic Biol Med 52: 2292-2301, 2012.
17. Basuroy S, Bhattacharya S, Leffler CW, and Parfenova H. Nox4 NADPH oxidase mediates oxidative stress and apo-ptosis caused by TNF-alpha in cerebral vascular endothe-lial cells. Am J Physiol Cell Physiol 296: C422-C432, 2009.
18. Bellner L, Martinelli L, Halilovic A, Patil K, Puri N, Dunn MW, Regan RF, and Schwartzman ML. Heme oxygenase-2 deletion causes endothelial cell activation marked by oxi-dative stress, inflammation, and angiogenesis. J Pharmacol Exp Ther 331: 925-932, 2009.
19. Benallaoua M, Francois M, Batteux F, Thelier N, Shyy JY, Fitting C, Tsagris L, Boczkowski J, Savouret JF, Corvol MT, Poiraudeau S, and Rannou F. Pharmacologic induction of heme oxygenase 1 reduces acute inflammatory arthritis in mice. Arthritis Rheum 56: 2585-2594, 2007.
20. Bergstraesser C, Hoeger S, Song H, Ermantraut L, Hottenrot M, Czymai T, Schmidt M, Goebeler M, Ponelies N, Stich C, Loesel R, Molema G, Seelen M, van Son W, Yard BA, and Rafat N. Inhibition of VCAM-1 expression in endothelial cells by CORM-3: the role of the ubiquitin-proteasome system, p38, and mitochondrial respiration. Free Radic Biol Med 52: 794-802, 2012.
21. Bonelli M, Savitskaya A, Steiner CW, Rath E, Bilban M, Wagner O, Bach FH, Smolen JS, and Scheinecker C. Heme oxygenase-1 end-products carbon monoxide and biliverdin ameliorate murine collagen induced arthritis. Clin Exp Rheumatol 30: 73-78, 2012.
22. Boyle JJ, Johns M, T. K, Nguyen AT, Game L, Schaer DJ, C. MJ, and Haskard DO. Activating transcription factor 1 directs Mhem atheroprotective macrophages via coordinated iron handling and foam cell protection. Circ Res 110: 20-33, 2012.
23. Brines R, Maicas N, Ferrandiz ML, Loboda A, Jozkowicz A, Dulak J, and Alcaraz MJ. Heme oxygenase-1 regulates the progression of K/BxN serum transfer arthritis. PLoS One 7: e52435, 2012.
24. Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AMK, and Soares MP. Carbon monoxide generated by heme oxygenase-1 suppresses endothelial cell apoptosis. J Exp Med 192: 1015-1026, 2000.
25. Bussolati B, Ahmed A, Pemberton H, C. LR, Di Carlo F, Haskard DO, and Mason JC. Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angio-genesis and inhibition of leukocytic infiltration. Blood 103: 761-766, 2004.
26. Bussolati B and Mason JC. Dual role of VEGF-induced heme-oxygenase-1 in angiogenesis. Antioxid Redox Signal 8: 1153-1163, 2006.
27. Caumartin Y, Stephen J, Deng JP, Lian D, Lan Z, Liu W, Garcia B, Jevnikar AM, Wang H, Cepinskas G, and Luke PP. Carbon monoxide-releasing molecules protect against ischemia-reperfusion injury during kidney transplantation. Kidney Int 79: 1080-1089, 2011.
28. Chen S, Sega M, and Agarwal A. "Lumen digestion" technique for isolation of aortic endothelial cells from heme oxygenase-1 knockout mice. Biotechniques 37: 84-89, 2004.
29. Chen YH, Lin SJ, Lin MW, Tsai HL, Kuo SS, Chen JW, Charng MJ, Wu TC, Chen LC, Ding YA, Pan WH, Jou YS, and Chau LY. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 111: 1-8, 2002.
30. Cheng C, Noordeloos AM, Jeney V, Soares MP, Moll F, Pasterkamp G, Serruys PW, and Duckers HJ. Heme oxygenase-1 determines atherosclerotic lesion progression into a vulnerable plaque. Circulation 119: 3017-3027, 2009.
31. Chlopicki S, Lomnicka M, Fedorowicz A, Grochal E, Kramkowski K, Mogielnicki A, Buczko W, and Motterlini R. Inhibition of platelet aggregation by carbon monoxide-releasing molecules (CO-RMs): comparison with NO donors. Naunyn Schmiedebergs Arch Pharmacol 385: 641-650, 2012.
32. Choi YK, Kim CK, Lee H, Jeoung D, Ha KS, Kwon YG, Kim KW, and Kim YM. Carbon monoxide promotes VEGF expression by increasing HIF-1alpha protein level via two distinct mechanisms, translational activation and stabilization of HIF-1alpha protein. J Biol Chem 285: 32116-32125, 2010.
33. Cisowski J, Loboda A, Jozkowicz A, Chen S, Agarwal A, and Dulak J. Role of heme oxygenase-1 in hydrogen peroxide-induced VEGF synthesis: effect of HO-1 knockout. Biochem Biophys Res Commun 326: 670-676, 2005.
34. Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, Devey LR, Wigmore SJ, Abbas A, Hewett PW, and Ahmed A. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 115: 1789-1797, 2007.
35. Cudmore MJ, Ahmad S, Sissaoui S, Ramma W, Ma B, Fu-jisawa T, Al-Ani B, Wang K, Cai M, Crispi F, Hewett PW, Gratacos E, Egginton S, and Ahmed A. Loss of Akt activity increases circulating soluble endoglin release in pre-eclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1. Eur Heart J 33: 1150-1158, 2012.
36. D'Amico G, Lam F, Hagen T, and Moncada S. Inhibition of cellular respiration by endogenously produced carbon monoxide. J Cell Sci 119: 2291-2298, 2006.
37. Dai G, Vaughn S, Zhang Y, Wang ET, Garcia-Cardena G, and Gimbrone MA, Jr. Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/Akt-dependent activation of Nrf2. Circ Res 101: 723-733, 2007.
38. Datla SR, Dusting GJ, Mori TA, Taylor CJ, Croft KD, and Jiang F. Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress. Hypertension 50: 636-642, 2007.
39. Dennery PA, Spitz DR, Yang G, Tatarov A, Lee CS, Shegog ML, and Poss KD. Oxygen toxicity and iron accumulation in the lungs of mice lacking heme oxygenase-2. J Clin Invest 101: 1001-1011, 1998.
40. Deramaudt BM, Braunstein S, Remy P, and Abraham NG. Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis. J Cell Biochem 68: 121-127, 1998.
41. Deshane J, Chen S, Caballero S, Grochot-Przeczek A, Was H, Li Calzi S, Lach R, Hock TD, Chen B, Hill-Kapturczak N, Siegal GP, Dulak J, Jozkowicz A, Grant MB, and Agarwal A. Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. J Exp Med 204: 605-618, 2007.
42. Devesa I, Ferrandiz ML, Guillen I, Cerda JM, and Alcaraz MJ. Potential role of heme oxygenase-1 in the progression of rat adjuvant arthritis. Lab Invest 85: 34-44, 2005.
43. Devesa I, Ferrandiz ML, Terencio MC, Joosten LAB, van den Berg WB, and Alcaraz MJ. Induction of heme oxyge-nase 1 modulation on the progression of murine collagen-induced arthritis. Arthritis Rheum 52: 3230-3238, 2005.
44. Doberer D, Haschemi A, Andreas M, Zapf TC, Clive B, Jeitler M, Heinzl H, Wagner O, Wolzt M, and Bilban M. Haem arginate infusion stimulates haem oxygenase-1 expression in healthy subjects. Br J Pharmacol 161: 1751-1762, 2010.
45. Dulak J, Jozkowicz A, Foresti R, Kasza A, Frick M, Huk I, Green CJ, Pachinger O, Weidinger F, and Motterlini R. Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid Redox Signal 4: 229-240, 2002.
46. Dulak J, Loboda A, Jazwa A, Zagorska A, Dorler J, Alber H, Dichtl W, Weidinger F, Frick M, and Jozkowicz A. Ator-vastatin affects several angiogenic mediators in human endothelial cells. Endothelium 12: 233-241, 2005.
47. Dulak J, Loboda A, Zagorska A, and Jozkowicz A. Complex role of heme oxygenase-1 in angiogenesis. Antioxid Redox Signal 6: 858-866, 2004.
48. Endler G, Exner M, Schillinger M, Marculescu R, Sunder-Plassmann R, Raith M, Jordanova N, Wojta J, Mannhalter C, Wagner OF, and Huber K. A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery disease. Thromb Haemost 91: 155-161, 2004.
49. Exner M, Minar E, Wagner O, and Schillinger M. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med 37: 1097-1104, 2004.
50. Faleo G, Neto JS, Kohmoto J, Tomiyama K, Shimizu H, Takahashi T, Wang Y, Sugimoto R, Choi AM, Stolz DB, Carrieri G, McCurry KR, Murase N, and Nakao A. Carbon monoxide ameliorates renal cold ischemia-reperfusion injury with an upregulation of vascular endothelial growth factor by activation of hypoxia-inducible factor. Transplantation 85: 1833-1840, 2008.
51. Fernandez M and Bonkovsky HL. Vascular endothelial growth factor increases heme oxygenase-1 protein expression in the chick embryo chorioallantoic membrane. Br J Pharmacol 139: 634-640, 2003.
52. Ferrandiz ML, Maicas N, Garcia-Arnandis I, Terencio MC, Motterlini R, Devesa I, Joosten LA, van den Berg WB, and Alcaraz MJ. Treatment with a CO-releasing molecule (CORM-3) reduces joint inflammation and erosion in mu-rine collagen-induced arthritis. Ann Rheum Dis 67: 1211-1217, 2008.
53. Filippo CD, Perretti M, Rossi F, Ferraraccio F, Motterlini R, and D'Amico M. Acute myocardial infarction in strepto-zotocin-induced hyperglycaemic rats: protection by a carbon monoxide-releasing molecule (CORM-3). Naunyn Schmiedebergs Arch Pharmacol 385: 137-144, 2012.
54. Fujii M, Inoguchi T, Sasaki S, Maeda Y, Zheng J, Kobayashi K, and Takayanagi R. Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase. Kidney Int 78: 905-919, 2010.
55. Goto S, Sampei K, Alkayed NJ, Dore S, and Koehler RC. Characterization of a new double-filament model of focal cerebral ischemia in heme oxygenase-2-deficient mice. Am J Physiol Regul Integr Comp Physiol 285: R222-R230, 2003.
56. Gozzelino R, Jeney V, and Soares MP. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 50: 323-354, 2010.
57. Greenwood J and Mason JC. Statins and the vascular endo-thelial inflammatory response. Trends Immunol 28: 88-98, 2007.
58. Grochot-Przeczek A, Lach R, Mis J, Skrzypek K, Gozdecka M, Sroczynska P, Dubiel M, Rutkowski A, Kozakowska M, Zagorska A, Walczynski J, Was H, Kotlinowski J, Drukala J, Kurowski K, Kieda C, Herault Y, Dulak J, and Jozkowicz A. Heme oxygenase-1 accelerates cutaneous wound healing in mice. PLoS One 4: e5803, 2009.
59. Grosser N, Abate A, Oberle S, Vreman HJ, Dennery PA, Becker JC, Pohle T, Seidman DS, and Schroder H. Heme oxygenase-1 induction may explain the antioxidant profile of aspirin. Biochem Biophys Res Commun 308: 956-960, 2003.
60. Hamdulay SS, Wang B, Birdsey GM, Ali F, Dumont O, Evans PC, Haskard DO, Wheeler-Jones CP, and Mason JC. Celecoxib activates PI-3K/Akt and mitochondrial redox signaling to enhance heme oxygenase-1-mediated anti-inflammatory activity in vascular endothelium. Free Radic Biol Med 48: 1013-1023, 2010.
61. Hartsfield CL. Cross talk between carbon monoxide and nitric oxide. Antioxid Redox Signal 4: 301-307, 2002.
62. Hartsfield CL, Alam J, and Choi AM. Differential signaling pathways of HO-1 gene expression in pulmonary and systemic vascular cells. Am J Physiol 277: L1133-L1141, 1999.
63. Hayashi S, Omata Y, Sakamoto H, Higashimoto Y, Hara T, Sagara Y, and Noguchi M. Characterization of rat heme oxygenase-3 gene. Implication of processed pseudogenes derived from heme oxygenase-2 gene. Gene 336: 241-250, 2004.
64. Hayashi S, Takamiya R, Yamaguchi T, Matsumoto K, Tojo SJ, Tamatani T, Kitajima M, Makino N, Ishimura Y, and Suematsu M. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ Res 85: 663-671, 1999.
65. Hill M, Pereira V, Chauveau C, Zagani R, Remy S, Tesson L, Mazal D, Ubillos L, Brion R, Asghar K, Mashreghi MF, Kotsch K, Moffett J, Doebis C, Seifert M, Boczkowski J, Osinaga E, and Anegon I. Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2, 3-dioxygenase. FASEB J 19: 1957-1968, 2005.
66. Hinkelmann U, Grosser N, Erdmann K, Schroder H, and Immenschuh S. Simvastatin-dependent up-regulation of heme oxygenase-1 via mRNA stabilization in human en-dothelial cells. Eur J Pharm Sci 41: 118-124, 2010.
67. Hirai K, Sasahira T, Ohmori H, Fujii K, and Kuniyasu H. Inhibition of heme oxygenase-1 by zinc protoporphyrin IX reduces tumor growth of LL/2 lung cancer in C57BL mice. Int J Cancer 120: 500-505, 2007.
68. Huang LE, Willmore WG, Gu J, Goldberg MA, and Bunn HF. Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling. J Biol Chem 274: 9038-9044, 1999.
69. Ishikado A, Nishio Y, Morino K, Ugi S, Kondo H, Makino T, Kashiwagi A, and Maegawa H. Low concentration of 4-hydroxy hexenal increases heme oxygenase-1 expression through activation of Nrf2 and antioxidative activity in vascular endothelial cells. Biochem Biophys Res Commun 402: 99-104, 2010.
70. Ishikawa K, Navab M, and Lusis AJ. Vasculitis, atherosclerosis, and altered HDL composition in heme-oxygenase-1-knockout mice. Int J Hypertens 2012: 948203, 2012.
71. Ishikawa K, Sugawara D, Goto J, Watanabe Y, Kawamura K, Shiomi M, Itabe H, and Maruyama Y. Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits. Circulation 104: 1831-1836, 2001.
72. Jansen T, Hortmann M, Oelze M, Opitz B, Steven S, Schell R, Knorr M, Karbach S, Schuhmacher S, Wenzel P, Munzel T, and Daiber A. Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin. J Mol Cell Cardiol 49: 186-195, 2010.
73. Jazwa A, Loboda A, Golda S, Cisowski J, Szelag M, Za-gorska A, Sroczynska P, Drukala J, Jozkowicz A, and Dulak J. Effect of heme and heme oxygenase-1 on vascular en-dothelial growth factor synthesis and angiogenic potency of human keratinocytes. Free Radic Biol Med 40: 1250-1263, 2006.
74. Jeney V, Balla J, Yachie A, Varga Z, Vercellotti GM, Eaton JW, and Balla G. Pro-oxidant and cytotoxic effects of circulating heme. Blood 100: 879-887, 2002.
75. Johnson FK, Durante W, Peyton KJ, and Johnson RA. Heme oxygenase inhibitor restores arteriolar nitric oxide function in dahl rats. Hypertension 41: 149-155, 2003.
76. Johnson FK and Johnson RA. Carbon monoxide promotes endothelium-dependent constriction of isolated gracilis muscle arterioles. Am J Physiol Regul Integr Comp Physiol 285: R536-R541, 2003.
77. Jones AW, Durante W, and Korthuis RJ. Heme oxygenase-1 deficiency leads to alteration of soluble guanylate cyclase redox regulation. J Pharmacol Exp Ther 335: 85-91, 2010.
78. Jozkowicz A, Cooke JP, Guevara I, Huk I, Funovics P, Pa-chinger O, Weidinger F, and Dulak J. Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF. Cardiovasc Res 51: 773-783, 2001.
79. Józkowicz A, Huk I, Nigisch A, Weigel G, Dietrich W, Motterlini R, and Dulak J. Heme oxygenase and angiogenic activity of endothelial cells: stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX. Antioxid Redox Signal 5: 155-162, 2003.
80. 2 on VEGF synthesis depends on the induction of heme oxygenase-1. Antioxid Re-dox Signal 4: 577-585, 2002.
81. Jozkowicz A, Was H, and Dulak J. Heme oxygenase-1 in tumors: is it a false friend? Antioxid Redox Signal 9: 2099-2117, 2007.
82. Juan SH, Lee TS, Tseng KW, Liou JY, Shyue SK, Wu KK, and Chau LY. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 104: 1519-1525, 2001.
83. Kaneda H, Ohno M, Taguchi J, Togo M, Hashimoto H, Ogasawara K, Aizawa T, Ishizaka N, and Nagai R. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol 22: 1680-1685, 2002.
84. Kato Y, Shimazu M, Kondo M, Uchida K, Kumamoto Y, Wakabayashi G, Kitajima M, and Suematsu M. Bilirubin rinse: a simple protectant against the rat liver graft injury mimicking heme oxygenase-1 preconditioning. Hepatology 38: 364-373, 2003.
85. Kawamura K, Ishikawa K, Wada Y, Kimura S, Matsumoto H, Kohro T, Itabe H, Kodama T, and Maruyama Y. Bilir-ubin from heme oxygenase-1 attenuates vascular endothe-lial activation and dysfunction. Arterioscler Thromb Vasc Biol 25: 155-160, 2005.
86. Kawashima A, Oda Y, Yachie A, Koizumi S, and Nakanishi I. Heme oxygenase-1 deficiency: the first autopsy case. Hum Pathol 33: 125-130, 2002.
87. Kikuchi G, Yoshida T, and Noguchi M. Heme oxygenase and heme degradation. Biochem Biophys Res Commun 338: 558-567, 2005.
88. Kim YM, Pae HO, Park JE, Lee YC, Woo JM, Kim NH, Choi YK, Lee BS, Kim SR, and Chung HT. Heme oxygenase in the regulation of vascular biology: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 14: 137-167, 2011.
89. Kinderlerer AR, Gregoire IP, Hamdulay SS, Steinberg R, Ali F, Silva G, Ali N, Haskard DO, Soares MP, and Mason JC. Heme-oxygenase-1 expression enhances vascular en-dothelial resistance to complement-mediated injury through induction of decay-accelerating factor. A role for bilirubin and ferritin. Blood 113: 1598-1607, 2009.
90. Kitamuro T, Takahashi K, Ogawa K, Udono-Fujimori R, Takeda K, Furuyama K, Nakayama M, Sun J, Fujita H, Hida W, Hattori T, Shirato K, Igarashi K, and Shibahara S. Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells. J Biol Chem 278: 9125-9133, 2003.
91. Kobayashi H, Takeno M, Saito T, Takeda Y, Kirino Y, Noyori K, Hayashi T, Ueda A, and Ishigatsubo Y. Regulatory role of heme oxygenase 1 in inflammation of rheumatoid arthritis. Arthritis Rheum 54: 1132-1142, 2006.
92. Kohmoto J, Nakao A, Kaizu T, Tsung A, Ikeda A, To-miyama K, Billiar TR, Choi AM, Murase N, and McCurry KR. Low-dose carbon monoxide inhalation prevents is-chemia/reperfusion injury of transplanted rat lung grafts. Surgery 140: 179-185, 2006.
93. Kovtunovych G, Eckhaus MA, Ghosh MC, Ollivierre-Wilson H, and Rouault TA. Dysfunction of the heme recycling system in heme oxygenase 1-deficient mice: effects on macrophage viability and tissue iron distribution. Blood 116: 6054-6062, 2010.
94. Kreiser D, Nguyen X, Wong R, Seidman D, Stevenson D, Quan S, Abraham N, and Dennery PA. Heme oxygenase-1 modulates fetal growth in the rat. Lab Invest 82: 687-692, 2002.
95. Kronke G, Kadl A, Ikonomu E, Bluml S, Furnkranz A, Sarembock IJ, Bochkov VN, Exner M, Binder BR, and Lei-tinger N. Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors. Arterioscler Thromb Vasc Biol 27: 1276-1282, 2007.
96. Lakkisto P, Kyto V, Forsten H, Siren JM, Segersvard H, Voipio-Pulkki LM, Laine M, Pulkki K, and Tikkanen I. Heme oxygenase-1 and carbon monoxide promote neo-vascularization after myocardial infarction by modulating the expression of HIF-1alpha, SDF-1alpha and VEGF-B. Eur J Pharmacol 635: 156-164, 2010.
97. Laniado-Schwartzman M. MA, Seta F, Dunn MW, Abraham NG, and Gronert K. Heme oxygenase-2 (HO-2) knockout mice display impaired corneal wound healing and marked corneal neovascularization. Invest Ophthalmol Vis Sci 46: E-abstract 3619, 2005.
98. Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, Semenza GL, and Choi AM. Hypoxia-inducible factor-1 mediates tran-scriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 272: 5375-5381, 1997.
99. Lee SE, Jeong SI, Kim GD, Yang H, Park CS, Jin YH, and Park YS. Upregulation of heme oxygenase-1 as an adaptive mechanism for protection against crotonaldehyde in human umbilical vein endothelial cells. Toxicol Lett 201: 240-248, 2011.
100. Lee TS, Chang CC, Zhu Y, and Shyy JY. Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation 110: 1296-1302, 2004.
101. Li T, Tian H, Zhao Y, An F, Zhang L, Zhang J, Peng J, Zhang Y, and Guo Y. Heme oxygenase-1 inhibits progression and destabilization of vulnerable plaques in a rabbit model of atherosclerosis. Eur J Pharmacol 672: 143-152, 2011.
102. Li Volti G, Sacerdoti D, Sangras B, Vanella A, Mezentsev A, Scapagnini G, Falck JR, and Abraham NG. Carbon monoxide signaling in promoting angiogenesis in human mi-crovessel endothelial cells. Antioxid Redox Signal 7: 704-710, 2005.
103. Li Volti G, Wang J, Traganos F, Kappas A, and Abraham NG. Differential effect of heme-oxygenase-1 in endothelial and smooth muscle cell cycle progression. Biochem Biophys Res Commun 296: 1077-1082, 2002.
104. Lin HH, Chen YH, Yet SF, and Chau LY. After vascular injury, heme oxygenase-1/carbon monoxide enhances re-endothelialization via promoting mobilization of circulating endothelial progenitor cells. J Thromb Haemost 7: 1401-1408, 2009.
105. Lin HH, Lai SC, and Chau LY. Heme oxygenase-1/carbon monoxide induces vascular endothelial growth factor expression via p38 kinase-dependent activation of Sp1. J Biol Chem 286: 3829-3838, 2011.
106. Lin PH, Chiang MT, and Chau LY. Ubiquitin-proteasome system mediates heme oxygenase-1 degradation through endoplasmic reticulum-associated degradation pathway. Biochim Biophys Acta 1783: 1826-1834, 2008.
107. Liu X, Wei J, Peng DH, Layne MD, and Yet SF. Absence of heme oxygenase-1 exacerbates myocardial ischemia/re-perfusion injury in diabetic mice. Diabetes 54: 778-784, 2005.
108. Liu XM, Peyton KJ, Shebib AR, Wang H, Korthuis RJ, and Durante W. Activation of AMPK stimulates heme oxyge-nase-1 gene expression and human endothelial cell survival. Am J Physiol Heart Circ Physiol 300: H84-H93, 2011.
109. Liu XM, Peyton KJ, Wang X, and Durante W. Sildenafil stimulates the expression of gaseous monoxide-generating enzymes in vascular smooth muscle cells via distinct signaling pathways. Biochem Pharmacol 84: 1045-1054, 2012.
110. Liu Y, Zhu B, Wang X, Luo L, Li P, Paty DW, and Cynader MS. Bilirubin as a potent antioxidant suppresses experimental autoimmune encephalomyelitis: implications for the role of oxidative stress in the development of multiple sclerosis. J Neuroimmunol 139: 27-35, 2003.
111. Loboda A, Jazwa A, Grochot-Przeczek A, Rutkowski AJ, Cisowski J, Agarwal A, Jozkowicz A, and Dulak J. Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 10: 1767-1812, 2008.
112. Maghzal GJ, Leck MC, Collinson E, Li C, and Stocker R. Limited role for the bilirubin-biliverdin redox amplification cycle in the cellular antioxidant protection by biliverdin reductase. J Biol Chem 284: 29251-29259, 2009.
113. Maines MD, Trakshel GM, and Kutty RK. Characterization of two constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible. J Biol Chem 261: 411-419, 1986.
114. Maruyama K, Morishita E, Yuno T, Sekiya A, Asakura H, Ohtake S, and Yachie A. Carbon monoxide (CO)-releasing molecule-derived CO regulates tissue factor and plasmin-ogen activator inhibitor type 1 in human endothelial cells. Thromb Res 130: e188-e193, 2012.
115. Matsumura M, Fukuda N, Kobayashi N, Umezawa H, Takasaka A, Matsumoto T, Yao EH, Ueno T, and Negishi N. Effects of atorvastatin on angiogenesis in hindlimb ischemia and endothelial progenitor cell formation in rats. J Atheroscler Thromb 16: 319-326, 2009.
116. Morita T and Kourembanas S. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest 96: 2676-2682, 1995.
117. Motterlini R, Foresti R, Bassi R, Calabrese V, Clark JE, and Green CJ. Endothelial heme oxygenase-1 induction by hypoxia. Modulation by inducible nitric-oxide synthase and S-nitrosothiols. J Biol Chem 275: 13613-13620, 2000.
118. Motterlini R, Haas B, and Foresti R. Emerging concepts on the anti-inflammatory actions of carbon monoxide-releasing molecules (CO-RMs). Med Gas Res 2: 28, 2012.
119. Motterlini R and Otterbein LE. The therapeutic potential of carbon monoxide. Nat Rev Drug Discov 9: 728-743, 2010.
120. Motterlini R, Sawle P, Hammad J, Bains S, Alberto R, Foresti R, and Green CJ. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule. FASEB J 19: 284-286, 2005.
121. Muchova L, Wong RJ, Hsu M, Morioka I, Vitek L, Zelenka J, Schroder H, and Stevenson DK. Statin treatment increases formation of carbon monoxide and bilirubin in mice: a novel mechanism of in vivo antioxidant protection. Can J Physiol Pharmacol 85: 800-810, 2007.
122. Nakagami T, Toyomura K, Kinoshita T, and Morisawa S. A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. Biochim Biophys Acta 1158: 189-193, 1993.
123. Nakao A, Kimizuka K, Stolz DB, Neto JS, Kaizu T, Choi AM, Uchiyama T, Zuckerbraun BS, Nalesnik MA, Otterbein LE, and Murase N. Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury. Am J Pathol 163: 1587-1598, 2003.
124. Nakao A, Murase N, Ho C, Toyokawa H, Billiar TR, and Kanno S. Biliverdin administration prevents the formation of intimal hyperplasia induced by vascular injury. Circulation 112: 587-591, 2005.
125. Nakao A, Otterbein LE, Overhaus M, Sarady JK, Tsung A, Kimizuka K, Nalesnik MA, Kaizu T, Uchiyama T, Liu F, Murase N, Bauer AJ, and Bach FH. Biliverdin protects the functional integrity of a transplanted syngeneic small bowel. Gastroenterology 127: 595-606, 2004.
126. Nakayama M, Takahashi K, Kitamuro T, Yasumoto K, Katayose D, Shirato K, Fujii-Kuriyama Y, and Shibahara S. Repression of heme oxygenase-1 by hypoxia in vascular endothelial cells. Biochem Biophys Res Commun 271: 665-671, 2000.
127. Nakayama M, Takahashi K, Komaru T, Fukuchi M, Shioiri H, Sato K, Kitamuro T, Shirato K, Yamaguchi T, Suematsu M, and Shibahara S. Increased expression of heme oxyge-nase-1 and bilirubin accumulation in foam cells of rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol 21: 1373-1377, 2001.
128. Nizamutdinova IT, Kim YM, Kim HJ, Seo HG, Lee JH, and Chang KC. Carbon monoxide (from CORM-2) inhibits high glucose-induced ICAM-1 expression via AMP-activated protein kinase and PPAR-gamma activations in endothelial cells. Atherosclerosis 207: 405-411, 2009.
129. Ollinger R, Bilban M, Erat A, Froio A, McDaid J, Tyagi S, Csizmadia E, Graca-Souza AV, Liloia A, Soares MP, Ot-terbein LE, Usheva A, Yamashita K, and Bach FH. Bilir-ubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation 112: 1030-1039, 2005.
130. Ollinger R, Yamashita K, Bilban M, Erat A, Kogler P, Thomas M, Csizmadia E, Usheva A, Margreiter R, and Bach FH. Bilirubin and biliverdin treatment of atherosclerotic diseases. Cell Cycle 6: 39-43, 2007.
131. Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, and Choi AM. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6: 422-428, 2000.
132. Otterbein LE, Otterbein SL, Ifedigbo E, Liu F, Morse DE, Fearns C, Ulevitch RJ, Knickelbein R, Flavell RA, and Choi AM. MKK3 mitogen-activated protein kinase pathway mediates carbon monoxide-induced protection against oxidant-induced lung injury. Am J Pathol 163: 2555-2563, 2003.
133. Otterbein LE, Zuckerbraun BS, Haga M, Liu F, Song R, Usheva A, Stachulak C, Bodyak N, Smith RN, Csizmadia E, Tyagi S, Akamatsu Y, Flavell RJ, Billiar TR, Tzeng E, Bach FH, Choi AM, and Soares MP. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 9: 183-190, 2003.
134. Overhaus M, Moore BA, Barbato JE, Behrendt FF, Doering JG, and Bauer AJ. Biliverdin protects against polymicrobial sepsis by modulating inflammatory mediators. Am J Physiol Gastrointest Liver Physiol 290: G695-G703, 2006.
135. Pae HO, Oh GS, Choi BM, Kim YM, and Chung HT. A molecular cascade showing nitric oxide-heme oxygenase-1-vascular endothelial growth factor-interleukin-8 sequence in human endothelial cells. Endocrinology 146: 2229-2238, 2005.
136. Paine A, Eiz-Vesper B, Blasczyk R, and Immenschuh S. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol 80: 1895-1903, 2010.
137. Parfenova H, Basuroy S, Bhattacharya S, Tcheranova D, Qu Y, Regan RF, and Leffler CW. Glutamate induces oxidative stress and apoptosis in cerebral vascular endothelial cells: contributions of HO-1 and HO-2 to cytoprotection. Am J Physiol Cell Physiol 290: C1399-C1410, 2006.
138. Peterson SJ, Frishman WH, and Abraham NG. Targeting heme oxygenase: therapeutic implications for diseases of the cardiovascular system. Cardiol Rev 17: 99-111, 2009.
139. Piantadosi CA. Biological chemistry of carbon monoxide. Antioxid Redox Signal 4: 259-270, 2002.
140. Pitchumony TS, Spingler B, Motterlini R, and Alberto R. Syntheses, structural characterization and CO releasing properties of boranocarbonate
141. Poss KD and Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 94: 10925-10930, 1997.
142. Prawan A, Kundu JK, and Surh YJ. Molecular basis of heme oxygenase-1 induction: implications for chemoprevention and chemoprotection. Antioxid Redox Signal 7: 1688-1703, 2005.
143. Pullikotil P, Chen H, Muniyappa R, Greenberg CC, Yang S, Reiter CE, Lee JW, Chung JH, and Quon MJ. Epigalloca-techin gallate induces expression of heme oxygenase-1 in endothelial cells via p38 MAPK and Nrf-2 that suppresses proinflammatory actions of TNF-alpha. J Nutr Biochem 23: 1134-1145, 2012.
144. Radhakrishnan N, Yadav SP, Sachdeva A, Pruthi PK, Sawhney S, Piplani T, Wada T, and Yachie A. Human heme oxygenase-1 deficiency presenting with hemolysis, nephritis, and asplenia. J Pediatr Hematol Oncol 33: 74-78, 2011.
145. Rochette L, Cottin Y, Zeller M, and Vergely C. Carbon monoxide: mechanisms of action and potential clinical implications. Pharmacol Ther 137: 133-152, 2013.
146. Rodella L, Lamon BD, Rezzani R, Sangras B, Goodman AI, Falck JR, and Abraham NG. Carbon monoxide and bili-verdin prevent endothelial cell sloughing in rats with type I diabetes. Free Radic Biol Med 40: 2198-2205, 2006.
147. Rueda B, Oliver J, Robledo G, Lopez-Nevot MA, Balsa A, Pascual-Salcedo D, Gonzalez-Gay MA, Gonzalez-Escribano MF, and Martin J. HO-1 promoter polymorphism associated with rheumatoid arthritis. Arthritis Rheum 56: 3953-3958, 2007.
148. Ryter SW, Xi S, Hartsfield CL, and Choi AM. Mitogen activated protein kinase (MAPK) pathway regulates heme oxygenase-1 gene expression by hypoxia in vascular cells. Antioxid Redox Signal 4: 587-592, 2002.
149. Salinas M, Wang J, Rosa de Sagarra M, Martin D, Rojo AI, Martin-Perez J, Ortiz de Montellano PR, and Cuadrado A. Protein kinase Akt/PKB phosphorylates heme oxygenase-1 in vitro and in vivo. FEBS Lett 578: 90-94, 2004.
150. Sarady-Andrews JK, Liu F, Gallo D, Nakao A, Overhaus M, Ollinger R, Choi AM, and Otterbein LE. Biliverdin administration protects against endotoxin-induced acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol 289: L1131-L1137, 2005.
151. Seldon MP, Silva G, Pejanovic N, Larsen R, Gregoire IP, Filipe J, Anrather J, and Soares MP. Heme oxygenase-1 inhibits the expression of adhesion molecules associated with endothelial cell activation via inhibition of NF-kappaB RelA phosphorylation at serine 276. J Immunol 179: 7840-7851, 2007.
152. Seta F, Bellner L, Rezzani R, Regan RF, Dunn MW, Abraham NG, Gronert K, and Laniado-Schwartzman M. Heme oxygenase-2 is a critical determinant for execution of an acute inflammatory and reparative response. Am J Pathol 169: 1612-1623, 2006.
153. Setty BN, Betal SG, Zhang J, and Stuart MJ. Heme induces endothelial tissue factor expression: potential role in he-mostatic activation in patients with hemolytic anemia. J Thromb Haemost 6: 2202-2209, 2008.
154. Shibahara S, Muller R, Taguchi H, and Yoshida T. Cloning and expression of cDNA for rat heme oxygenase. Proc Natl Acad Sci USA 82: 7865-7869, 1985.
155. Shih RH and Yang CM. Induction of heme oxygenase-1 attenuates lipopolysaccharide-induced cyclooxygenase-2 expression in mouse brain endothelial cells. J Neuroin-flammation 7: 86, 2010.
156. Silva G, Cunha A, Gregoire IP, Seldon MP, and Soares MP. The antiapoptotic effect of heme oxygenase-1 in endothelial cells involves the degradation of p38 alpha MAPK isoform. J Immunol 177: 1894-1903, 2006.
157. Siner JM, Jiang G, Cohen ZI, Shan P, Zhang X, Lee CG, Elias JA, and Lee PJ. VEGF-induced heme oxygenase-1 confers cytoprotection from lethal hyperoxia in vivo. FASEB J 21: 1422-1432, 2007.
158. Soares MP, Seldon MP, Gregoire IP, Vassilevskaia T, Berberat PO, Yu J, Tsui TY, and Bach FH. Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol 172: 3553-3563, 2004.
159. Song H, Bergstrasser C, Rafat N, Hoger S, Schmidt M, Endres N, Goebeler M, Hillebrands JL, Brigelius-Flohe R, Banning A, Beck G, Loesel R, and Yard BA. The carbon monoxide releasing molecule (CORM-3) inhibits expression of vascular cell adhesion molecule-1 and E-selectin independently of haem oxygenase-1 expression. Br J Pharmacol 157: 769-780, 2009.
160. Song H, Hoeger S, Hillebrands JL, Mandel I, Loesel R, Beck G, Schilling L, Schnuelle P, and Yard B. CORMs protect endothelial cells during cold preservation, resulting in inhibition of intimal hyperplasia after aorta transplantation in rats. Transpl Int 23: 1144-1153, 2010.
161. Stein AB, Guo Y, Tan W, Wu WJ, Zhu X, Li Q, Luo C, Dawn B, Johnson TR, Motterlini R, and Bolli R. Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction. J Mol Cell Cardiol 38: 127-134, 2005.
162. Stocker R and Perrella MA. Heme oxygenase-1: a novel drug target for atherosclerotic diseases? Circulation 114: 2178-2189, 2006.
163. Stone JR and Marletta MA. Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry 33: 5636-5640, 1994.
164. Sukumari-Ramesh S, Laird MD, Singh N, Vender JR, Al-leyne CH, Jr., and Dhandapani KM. Astrocyte-derived glutathione attenuates hemin-induced apoptosis in cerebral microvascular cells. Glia 58: 1858-1870, 2010.
165. Sun B, Zou X, Chen Y, Zhang P, and Shi G. Preconditioning of carbon monoxide releasing molecule-derived CO attenuates LPS-induced activation of HUVEC. Int J Biol Sci 4: 270-278, 2008.
166. Sunamura M, Duda DG, Ghattas MH, Lozonschi L, Motoi F, Yamauchi J, Matsuno S, Shibahara S, and Abraham NG. Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis 6: 15-24, 2003.
167. Suzuki M, Iso-o N, Takeshita S, Tsukamoto K, Mori I, Sato T, Ohno M, Nagai R, and Ishizaka N. Facilitated angiogenesis induced by heme oxygenase-1 gene transfer in a rat model of hindlimb ischemia. Biochem Biophys Res Commun 302: 138-143, 2003.
168. Hoen PA, Van der Lans CA, Van Eck M, Bijsterbosch MK, Van Berkel TJ, and Twisk J. Aorta of ApoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes. Circ Res 93: 262-269, 2003.
169. Taha H, Skrzypek K, Guevara I, Nigisch A, Mustafa S, Grochot-Przeczek A, Ferdek P, Was H, Kotlinowski J, Ko-zakowska M, Balcerczyk A, Muchova L, Vitek L, Weigel G, Dulak J, and Jozkowicz A. Role of heme oxygenase-1 in human endothelial cells: lesson from the promoter allelic variants. Arterioscler Thromb Vasc Biol 30: 1634-1641, 2010.
170. Tang YL, Tang Y, Zhang YC, Qian K, Shen L, and Phillips MI. Improved graft mesenchymal stem cell survival in is-chemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 46: 1339-1350, 2005.
171. Terry CM, Clikeman JA, Hoidal JR, and Callahan KS. TNF-alpha and IL-1alpha induce heme oxygenase-1 via protein kinase C, Ca2+, and phospholipase A2 in endothelial cells. Am J Physiol 276: H1493-H1501, 1999.
172. Thorup C, Jones CL, Gross SS, Moore LC, and Goligorsky MS. Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS. Am J Physiol 277: F882-F889, 1999.
173. Tongers J, Knapp J-M, Korf M, Kempf T, Limbourg A, Limbourg FP, Li Z, Fraccarollo D, Bauersachs J, Han X, Drexler H, Fiedler B, and Wollert KC. Haem oxygenase promotes progenitor cell mobilization, neovascularization, and functional recovery after critical hind-limb ischaemia in mice. Cardiovasc Res 294-300: 294-300, 2008.
174. True AL, Olive M, Boehm M, San H, Westrick RJ, Ragha-vachari N, Xu X, Lynn EG, Sack MN, Munson PJ, Gladwin MT, and Nabel EG. Heme oxygenase-1 deficiency accelerates formation of arterial thrombosis through oxidative damage to the endothelium, which is rescued by inhaled carbon monoxide. Circ Res 101: 893-901, 2007.
175. Uchiyama T, Atsuta H, Utsugi T, Ohyama Y, Nakamura T, Nakai A, Nakata M, Maruyama I, Tomura H, Okajima F, Tomono S, Kawazu S, Nagai R, and Kurarbayashi M. Simvastatin induces heat shock factor 1 in vascular endo-thelial cells. Atherosclerosis 188: 265-273, 2006.
176. Vidavalur R, Penumathsa SV, Zhan L, Thirunavukkarasu M, and Maulik N. Sildenafil induces angiogenic response in human coronary arteriolar endothelial cells through the expression of thioredoxin, hemeoxygenase and vascular endothelial growth factor. Vascul Pharmacol 45: 91-95, 2006.
177. Visner GA, Lu F, Zhou H, Liu J, Kazemfar K, and Agarwal A. Rapamycin induces heme oxygenase-1 in human pulmonary vascular cells: implications in the antiproliferative response to rapamycin. Circulation 107: 911-916, 2003.
178. Wagener FA, Toonen EJ, Wigman L, Fransen J, Creemers MC, Radstake TR, Coenen MJ, Barrera P, van Riel PL, and Russel FG. HMOX1 promoter polymorphism modulates the relationship between disease activity and joint damage in rheumatoid arthritis. Arthritis Rheum 58: 3388-3393, 2008.
179. Wagener FA, Volk HD, Willis D, Abraham NG, Soares MP, Adema GJ, and Figdor CG. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev 55: 551-571, 2003.
180. Wang LJ, Lee TS, Lee FY, Pai RC, and Chau LY. Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 152: 711-720, 1998.
181. Wang X, Wang Y, Kim HP, Nakahira K, Ryter SW, and Choi AM. Carbon monoxide protects against hyperoxia-induced endothelial cell apoptosis by inhibiting reactive oxygen species formation. J Biol Chem 282: 1718-1726, 2007.
182. Was H, Cichon T, Smolarczyk R, Rudnicka D, Stopa M, Chevalier C, Leger JJ, Lackowska B, Grochot A, Bojkowska K, Ratajska A, Kieda C, Szala S, Dulak J, and Jozkowicz A. Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice. Am J Pathol 169: 2181-2198, 2006.
183. Was H, Sokolowska M, Sierpniowska A, Dominik P, Skrzypek K, Lackowska B, Pratnicki A, Grochot-Przeczek A, Taha H, Kotlinowski J, Kozakowska M, Mazan A, Nowak W, Muchova L, Vitek L, Ratajska A, Dulak J, and Jozkowicz A. Effects of heme oxygenase-1 on induction and development of chemically induced squamous cell carcinoma in mice. Free Radic Biol Med 51: 1717-1726, 2011.
184. Wegiel B, Gallo DJ, Raman KG, Karlsson JM, Ozanich B, Chin BY, Tzeng E, Ahmad S, Ahmed A, Baty CJ, and Ot-terbein LE. Nitric oxide-dependent bone marrow progenitor mobilization by carbon monoxide enhances endothelial repair after vascular injury. Circulation 121: 537-548, 2010.
185. Wegiel B, Hanto DW, and Otterbein LE. The social network of carbon monoxide in medicine. Trends Mol Med 19: 3-11, 2013.
186. Wei Y, Chen P, de Bruyn M, Zhang W, Bremer E, and Helfrich W. Carbon monoxide-releasing molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats. BMC Gastroenterol 10: 42, 2010.
187. Wei Y, Liu XM, Peyton KJ, Wang H, Johnson FK, Johnson RA, and Durante W. Hypochlorous acid-induced heme oxygenase-1 gene expression promotes human endothelial cell survival. Am J Physiol Cell Physiol 297: C907-C915, 2009.
188. Wenzel P, Oelze M, Coldewey M, Hortmann M, Seeling A, Hink U, Mollnau H, Stalleicken D, Weiner H, Lehmann J, Li H, Forstermann U, Munzel T, and Daiber A. Heme oxygenase-1: a novel key player in the development of tolerance in response to organic nitrates. Arterioscler Thromb Vasc Biol 27: 1729-1735, 2007.
189. Wu BJ, Chen K, Barter PJ, and Rye KA. Niacin Inhibits Vascular Inflammation via the Induction of Heme Oxyge-nase-1. Circulation 125: 150-158, 2012.
190. Wu BJ, Kathir K, Witting PK, Beck K, Choy K, Li C, Croft KD, Mori TA, Tanous D, Adams MR, Lau AK, and Stocker R. Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging. J Exp Med 203: 1117-1127, 2006.
191. Wu BJ, Midwinter RG, Cassano C, Beck K, Wang Y, Changsiri D, Gamble JR, and Stocker R. Heme oxygenase-1 increases endothelial progenitor cells. Arterioscler Thromb Vasc Biol 29: 1537-1542, 2009.
192. Wu CC, Hsu MC, Hsieh CW, Lin JB, Lai PH, and Wung BS. Upregulation of heme oxygenase-1 by Epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways. Life Sci 78: 2889-2897, 2006.
193. Wu J, Ma J, Fan ST, Schlitt HJ, and Tsui TY. Bilirubin derived from heme degradation suppresses MHC class II expression in endothelial cells. Biochem Biophys Res Commun 338: 890-896, 2005.
194. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, and Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103: 129-135, 1999.
195. Yamashita K, McDaid J, Ollinger R, Tsui TY, Berberat PO, Usheva A, Csizmadia E, Smith RN, Soares MP, and Bach FH. Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts. FASEB J 18: 765-767, 2004.
196. Yet SF, Layne MD, Liu X, Chen YH, Ith B, Sibinga NE, and Perrella MA. Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J 17: 1759-1761, 2003.
197. Yet SF, Perrella MA, Layne MD, Hsieh CM, Maemura K, Kobzik L, Wiesel P, Christou H, Kourembanas S, and Lee ME. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest 103: R23-R29, 1999.
198. Zabalgoitia M, Colston JT, Reddy SV, Holt JW, Regan RF, Stec DE, Rimoldi JM, Valente AJ, and Chandrasekar B. Carbon monoxide donors or heme oxygenase-1 (HO-1) overexpression blocks interleukin-18-mediated NF-kappaB-PTEN-dependent human cardiac endothelial cell death. Free Radic Biol Med 44: 284-298, 2008.
199. Zhang X, Shan P, Jiang G, Zhang SS, Otterbein LE, Fu XY, and Lee PJ. Endothelial STAT3 is essential for the protective effects of HO-1 in oxidant-induced lung injury. FASEB J 20: 2156-2158, 2006.
200. Zhang X, Shan P, Otterbein LE, Alam J, Flavell RA, Davis RJ, Choi AM, and Lee PJ. Carbon monoxide inhibition of apo-ptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase 3. J Biol Chem 278: 1248-1258, 2003.